|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/407 | |
| A61K 31/167 | |||
| A61K 9/08 | |||
| A61P 25/06 | |||
| A61P 29/00 |
| (11) | Number of the document | 1835911 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05854564.1 |
| Date of filing the European patent application | 2005-12-15 | |
| (97) | Date of publication of the European application | 2007-09-26 |
| (45) | Date of publication and mention of the grant of the patent | 2012-08-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/045883 |
| Date | 2005-12-15 |
| (87) | Number | WO 2006/071601 |
| Date | 2006-07-06 |
| (30) | Number | Date | Country code |
| 639022 P | 2004-12-23 | US |
| (72) |
WHITING, Roger, US
THIRUCOTE, Ramachandran, US
|
| (73) |
ROXRO Pharma, Inc.,
535 Middlefield Road, Suite 240, Menlo Park, CA 94025-3444,
US
|
| (54) | THERAPEUTIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF KETOROLAC |
| THERAPEUTIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF KETOROLAC |